Location History:
- Albigny sur Saone, FR (2003 - 2010)
- Irigny, FR (2012)
Company Filing History:
3 out of 819 
3 out of 81 
1 out of 639 
Years Active: 2003-2012
Title: Guy Vernet: Innovator in Oligonucleotide Technology
Introduction
Guy Vernet is a notable inventor based in Albigny sur Saone, France. He has made significant contributions to the field of molecular biology, particularly in the development of oligonucleotides for diagnostic purposes. With a total of 5 patents to his name, Vernet's work has had a substantial impact on the detection of viral genes.
Latest Patents
Among his latest patents is a groundbreaking invention related to oligonucleotides for diagnosing the presence of H5 and N1 genes of the Influenza A virus. This invention involves a double pair of oligonucleotides designed to amplify two target sequences located in the H5 and N1 genes of the Influenza A virus genome. The oligonucleotides range in length from 10 to 50 nucleotides and include at least one fragment of 10 consecutive nucleotides derived from specific sequences. This invention is particularly applicable in the field of diagnosis, providing a method and kit for detecting these viral genes. Another significant patent focuses on the amplification of HIV-1 sequences for detecting drug-resistance mutations. This patent discloses sequences of nucleic acid oligonucleotides for amplifying different portions of the gag and pol genes of HIV-1, along with methods for detecting these amplified sequences in biological samples.
Career Highlights
Throughout his career, Guy Vernet has worked with prominent companies in the biotechnology sector, including Gen-Probe, Inc. and bioMérieux SA. His experience in these organizations has allowed him to refine his expertise in oligonucleotide technology and diagnostics.
Collaborations
Vernet has collaborated with notable professionals in his field, including Yeasing Y Yang and Steven T Brentano. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Guy Vernet's contributions to the field of oligonucleotide technology and diagnostics are noteworthy. His innovative patents and collaborations have significantly advanced the capabilities of viral gene detection. His work continues to influence the field and improve diagnostic methods for various viral infections.